PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10391670-0	1999	Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy.	Lisinopril	11-21	BCL2 apoptosis regulator	Homo sapiens	46-51	
10391670-3	1999	A 6-month course of 5 mg/day lisinopril given to subjects with proteinuria significantly reduced blood bcl-2 concentrations and caused a reduction in proteinuria.	Lisinopril	29-39	BCL2 apoptosis regulator	Homo sapiens	103-108	
10075388-0	1999	Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration.	Lisinopril	60-70	BCL2 apoptosis regulator	Homo sapiens	8-13	
10075388-4	1999	Treatment of hypertensive patients with hypotensive drugs caused a reduction in bcl-2 concentrations, which was more marked after administration of lisinopril than of nifedipine.	Lisinopril	148-158	BCL2 apoptosis regulator	Homo sapiens	80-85	
10075388-6	1999	Moreover, lisinopril and nifedipine appear to be capable of reducing bcl-2 concentrations, with potentially beneficial effects on vascular modifications in patients with hypertension.	Lisinopril	10-20	BCL2 apoptosis regulator	Homo sapiens	69-74